Microdosing Psilocybin Mushrooms Improves Mood And Mental Health After One Month, New Study Finds

Lindsey Bartlett Contributor
I cover the cannabis industry, psychedelics, culture, and innovation.

Jul 5, 2022,01:39pm EDT

A new study published in Nature: Scientific Reports has observed significant benefits to mood and mental health after one month of microdosing psilocybin mushrooms.

Mushroom microdosers saw greater improvements across the DASS domains of Depression, Anxiety, and Stress. The study indicates that they found no difference in these results across genders, but it did find that the microdose cognitive efficacy was higher performing in people aged under 55.

The study looked at 1133 people over the course of two years. All subjects were over 18 years old, able to read in English, and had access to an iPhone iOS device where participants recorded their results. Scientific Reports is a peer-reviewed, open-access scientific journal published online by Nature Portfolio.

Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls – Scientific Reports
The study was conducted by a team of experts in the fields of psychology and mycology: Joseph M. Rootman, Department of Psychology, University of British Columbia, Kelowna, BC, Canada; Maggie Kiraga, an employee of Quantified Citizen Technologies. Pamela Kryskow, a member of the clinical advisory board of Numinus Wellness, co-founder of MycoMedica Life Sciences, and on the Scientific & Medical Advisory Board; Kalin Harvey; Paul Stamets, who founded Fungi Perfecti, LLC; Eesmyal Santos-Brault; Kim P. C. Kuypers; and Zach Walsh, a member of the Advisory Board of the Multidisciplinary Association for Psychedelic Studies (MAPS) Canada and MycoMedica Life Sciences.

Author admin

You Might Also Like

New study provides further support for psilocybin’s potential to treat depressive symptoms

Study Suggests Promise of Psilocybin in Treating Depressive Symptoms

Alcohol Addiction: One Day, Treating with a Psychedelic Derived from Hallucinogenic Mushrooms or LSD?